Pay in 4 interest-free payments of $5.02 Learn more
Ships within 48 hours · Estimated delivery Oct 26 - Oct 31
Revenue at Risk: The Numbers That Drive Biosimilar Entry Decisions A biosimilar developer deciding whether to enter a market must model expected revenue under three scenarios: first entry with several years of limited competition, entry alongside two to three competitors in an oligopolistic market, and entry as a fifth or sixth competitor in a crowded market with aggressive price competition
Este artculo examina la evidencia actual sobre los efectos cardiovasculares de tirzepatida, sus mecanismos de accin y consideraciones clnicas importantes para pacientes y profesionales de la salud
CONSORT Statement 2001 Checklist
Melanotan II is supplied as a lyophilized powder to support stability during storage and shipping
In addition, semaglutide has been shown to reduce apoptosis and ameliorate cognitive impairment in cerebrovascular disease (27), Alzheimer's disease (AD) (28) and Parkinson's disease (PD) (29)
US$ 23.90
US$ 26.67
US$ 28.03
US$ 21.23
